These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5869370)

  • 21. [1967 prices of drugs].
    Sven Farm Tidskr; 1966 Nov; 70(33):794-801. PubMed ID: 5980006
    [No Abstract]   [Full Text] [Related]  

  • 22. [The basis of drug rates].
    Sven Farm Tidskr; 1966 Jun; 70(18):468-73. PubMed ID: 5968462
    [No Abstract]   [Full Text] [Related]  

  • 23. [Committee for the Study of Adverse Effects of Drugs].
    Sven Farm Tidskr; 1966 Feb; 70(6):185-7. PubMed ID: 5961738
    [No Abstract]   [Full Text] [Related]  

  • 24. [Report on side-effects. I].
    Lakartidningen; 1966 Feb; 63(6):507. PubMed ID: 5924683
    [No Abstract]   [Full Text] [Related]  

  • 25. [Social bias--or medical?].
    Eriksson N
    Lakartidningen; 1966 Aug; 63(31):2874-5. PubMed ID: 5919126
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacy prices for 1965].
    Sven Farm Tidskr; 1966 Mar; 70(8):219-23. PubMed ID: 5912267
    [No Abstract]   [Full Text] [Related]  

  • 27. [Transgenic goats in the world's pharmaceutical industry in the XXI century].
    Gol'dman IL; Kadulin SG; Razin SV
    Genetika; 2002 Jan; 38(1):5-21. PubMed ID: 11852794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Regulations for industrial establishments devoted to the manufacture of raw materials for compounding drugs and for laboratories or factories].
    Salud Publica Mex; 1982; 24(2):212-9. PubMed ID: 7112260
    [No Abstract]   [Full Text] [Related]  

  • 29. [Notification of adverse drug-effects].
    Sven Farm Tidskr; 1965 Sep; 69(27):798. PubMed ID: 5869371
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tendencies in drug research].
    Westerling R
    Sven Farm Tidskr; 1966 Apr; 70(12):293-6. PubMed ID: 5911655
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prescribed drug benefits. Replies].
    Sven Farm Tidskr; 1966 Dec; 70(34):815-7. PubMed ID: 5981162
    [No Abstract]   [Full Text] [Related]  

  • 32. World's most admired companies. Medco's big bio bet.
    Kimes M
    Fortune; 2008 Oct; 158(8):24. PubMed ID: 19323344
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prescribed drug benefits. Reply of the Apothecaries Society].
    Sven Farm Tidskr; 1966 Nov; 70(32):761-5. PubMed ID: 5979056
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prescription labeling of over-the-counter drugs].
    Westerling R
    Sven Farm Tidskr; 1966 Apr; 70(10):265-6. PubMed ID: 5916551
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prescribed drug benefits. Remarks from Central Organizations].
    Sven Farm Tidskr; 1966 Dec; 70(35):862-4. PubMed ID: 5975562
    [No Abstract]   [Full Text] [Related]  

  • 36. [Quality assurance of the basic list of drugs].
    Wallén L; von Bahr C
    Lakartidningen; 1996 Oct; 93(41):3550, 3552. PubMed ID: 8965505
    [No Abstract]   [Full Text] [Related]  

  • 37. [Information for consulting physicians regarding the law on general insurance].
    Jochnick CA
    Lakartidningen; 1966 Aug; 63(31):2878-9. PubMed ID: 5919127
    [No Abstract]   [Full Text] [Related]  

  • 38. [Control of the quality of drug doses in the framework of therapeutic surveillance: Asqualab program 1997-1999].
    Feuillu A; Anglard I; Morel I; Palette C; Marquet P; Roux A; Vassault A
    Ann Biol Clin (Paris); 2000; 58(5):630-6. PubMed ID: 11022111
    [No Abstract]   [Full Text] [Related]  

  • 39. [Juglans regia L. - in the Swedish pharmacopoeia and elsewhere].
    Ljungdell J
    Sydsven Medicinhist Sallsk Arsskr; 1982; 19():54-62. PubMed ID: 11628824
    [No Abstract]   [Full Text] [Related]  

  • 40. Setting up a laboratory for therapeutic drug monitoring.
    Kalman SM
    Hosp Formul; 1982 Apr; 17(4):568-70, 573. PubMed ID: 10317192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.